Tango Biosciences Inc.
Chicago, IL · Biotech · Private
Phage display vectors and combinatorial peptide libraries for identifying protease substrate profiles
- Grants
- $3.0M
- 12 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720182019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Generating sandwich assays through MegaSTAR | $223,556 | |
| Federal grant | Department of Health and Human Services · Phase I · Generating sandwich assays through MegaSTAR | $223,556 | |
| Federal grant | Department of Health and Human Services · Phase I · Array Based Affinity Selection | $224,009 | |
| Federal grant | Department of Health and Human Services · Phase I · Array Based Affinity Selection | $407,327 | |
| Federal grant | Department of Health and Human Services · Phase I · Array Based Affinity Selection | $183,318 | |
| Federal grant | Department of Health and Human Services · Phase I · Building a Toolbox to Study the SARS-CoV-2 Proteome | $222,329 | |
| Federal grant | Department of Health and Human Services · Phase I · Building a Toolbox to Study the SARS-CoV-2 Proteome | $222,329 | |
| Federal grant | Department of Health and Human Services · Phase I · Building a pipeline to generate affinity reagents to phosphothreonine epitopes | $222,933 | |
| Federal grant | Department of Health and Human Services · Phase I · Generating fast-on rate reagents for lateral flow assays to detect HCV | $275,606 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · High-throughput profiling of proteases with phage and arrays | $256,776 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · High-throughput profiling of proteases with phage and arrays | $256,776 | |
| Federal grant | Department of Health and Human Services · Phase I · The Avidimer Platform - a molecular toolbox to accelerate proximity research and drug discovery | $314,363 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2042 | JPT America, Inc. | — | $600K |
| 2043 | ALGOMEDIX, INC. | — | — |
| 2044 | Scale-Up International Inc. | — | $84K |
| 2045 | Tango Biosciences Inc. | — | — |
| 2046 | AVIARA PHARMACEUTICALS, INC. | — | — |
| 2047 | BLR BIO, LLC | — | — |
| 2048 | KEYBIOME INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.